The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
Open accessAbstract
Chemoresistance remains the major obstacle to achieve optimal prognosis in gastric cancer patients, and the underlying molecular mechanisms of cancer-associated fibroblasts (CAFs) in gastric cancer chemoresistance remain poorly understood. We identified the high pretherapeutical serum IL-8 level in gastric cancer patients was associated with poor response to platinum-based therapy, and it increased gradually during neoadjuvant chemotherapy and it decreased after radical surgery. Immunohistochemistry assays showed that IL-8 was highly expressed in gastric cancer tissues in chemoresistant patients, and located in CAFs. Primary CAFs produced more IL-8 than the corresponding normal fibroblasts, and human stomach fibroblast line Hs738 secreted more IL-8 after co-cultured with conditioned media from AGS or MGC-803 cells. IL-8 increased the IC50 of cisplatin (CDDP) in AGS or MGC-803 in vitro. Simultaneously, IL-8 treatment enhanced the expression of PI3K, phosphorylated-AKT (p-AKT), phosphorylated-IKb (p-IKb), phosphorylated-p65 (p-p65) and ABCB1, and ABCB1 and p-p65 were overexpressed in tumor tissues of chemoresistant patients. Collectively, CAFs derived IL-8 promotes chemoresistance in human gastric cancer via NF-κB activation and ABCB1 up-regulation. Our study provides a novel strategy to improve the chemotherapeutical efficacy and the prognosis of gastric cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Japanese gastric cancer treatment guidelines 2014 (ver. 4)
Japanese Gastric Cancer Association (2017) · Gastric Cancer · doi:10.1007/s10120-016-0622-4 · Cited by 2,429
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
Sasako, M., Sakuramoto, S., Katai, H., Kinoshita, T., Furukawa, H., Yamaguchi, T., Nashimoto, A., Fujii, M., Nakajima, T., & Ohashi, Y. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5908 · Cited by 1,434
Noh, S. H., Park, S. R., Yang, H.-K., Chung, H. C., Chung, I.-J., Kim, S.-W., Kim, H.-H., Choi, J.-H., Kim, H.-K., Yu, W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70473-5 · Cited by 1,049
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2743 · Cited by 334
IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment
Karakasheva, T. A., Lin, E. W., Tang, Q., Qiao, E., Waldron, T. J., Soni, M., Klein-Szanto, A. J., Sahu, V., Basu, D., Ohashi, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2268 · Cited by 250
Chemoresistance and the Self-Maintaining Tumor Microenvironment
Yeldag, G., Rice, A., & Del Río Hernández, A. (2018) · Cancers · doi:10.3390/cancers10120471 · Cited by 214
Hessmann, E., Patzak, M. S., Klein, L., Chen, N., Kari, V, Ramu, I., Bapiro, T. E., Frese, K. K., Gopinathan, A., Richards, F. M., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-311954 · Cited by 202
Incidence and mortality of stomach cancer in China, 2014
Yang, L., Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), B. O. F. C. P. A. C., Zheng, R., Wang, N., Yuan, Y., Liu, S., Li, H., Zhang, S., Zeng, H., Chen, W., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.03.01 · Cited by 196
Izumi, D., Ishimoto, T., Miyake, K., Sugihara, H., Eto, K., Sawayama, H., Yasuda, T., Kiyozumi, Y., Kaida, T., Kurashige, J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29864 · Cited by 181
Medical management of gastric cancer: a 2017 update
Charalampakis, N., Economopoulou, P., Kotsantis, I., Tolia, M., Schizas, D., Liakakos, T., Elimova, E., Ajani, J. A., & Psyrri, A. (2018) · Cancer Medicine · doi:10.1002/cam4.1274 · Cited by 179
Li, P., Shan, J.-X., Chen, X.-H., Zhang, D., Su, L.-P., Huang, X.-Y., Yu, B.-Q., Zhi, Q.-M., Li, C.-L., Wang, Y.-Q., et al. (2015) · Cell Research · doi:10.1038/cr.2015.51 · Cited by 173
Mechanisms of Resistance to Chemotherapy in Gastric Cancer
Marin, J. J. G., Al-Abdulla, R., Lozano, E., Briz, O., Bujanda, L., M. Banales, J., & Macias, R. I. R. (2016) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150803125121 · Cited by 170
Molecular mechanisms of chemoresistance in gastric cancer
Shi, W.-J., & Gao, J.-B. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i9.673 · Cited by 164
Wang, X., Zhou, Q., Yu, Z., Wu, X., Chen, X., Li, J., Li, C., Yan, M., Zhu, Z., Liu, B., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30801 · Cited by 118
Cancer‐associated fibroblasts: Secretions, interactions, and therapy
Farhood, B., Najafi, M., & Mortezaee, K. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27703 · Cited by 114
A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis
Liu, C., Zhang, Y., Lim, S., Hosaka, K., Yang, Y., Pavlova, T. V., Alkasalias, T., Hartman, J., Jensen, L. D., Xing, X., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0101 · Cited by 90
Self-citationMa, J., Song, X., Xu, X., & Mou, Y. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.031 · Cited by 78
Wang, J., Hu, W., Wang, K., Yu, J., Luo, B., Luo, G., Wang, W., Wang, H., Li, J., & Wen, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3371 · Cited by 73
Wen, J., Wang, Y., Gao, C., Zhang, G., You, Q., Zhang, W., Zhang, Z., Wang, S., Peng, G., & Shen, L. (2018) · Oncogene · doi:10.1038/s41388-018-0208-1 · Cited by 67
Self-citationGenomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer
Park, H., Cho, S., Kim, H., Na, D., Han, J. Y., Chae, J., Park, C., Park, O.-K., Min, S., Kang, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507491112 · Cited by 66
Ma, Y., Zhu, J., Chen, S., Li, T., Ma, J., Guo, S., Hu, J., Yue, T., Zhang, J., Wang, P., et al. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0599-7 · Cited by 43
The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
Wang, Z., Liu, H., Shen, Z., Wang, X., Zhang, H., Qin, J., Xu, J., Sun, Y., & Qin, X. (2015) · BMC Cancer · doi:10.1186/s12885-015-1793-9 · Cited by 35
Recent updates in perioperative chemotherapy and recurrence pattern of gastric cancer
Kanaji, S., Suzuki, S., Matsuda, Y., Hasegawa, H., Yamamoto, M., Yamashita, K., Oshikiri, T., Matsuda, T., Nakamura, T., Sumi, Y., et al. (2018) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12199 · Cited by 33
Fitzgerald, T. L., Efird, J. T., Bellamy, N., Russo, S. M., Jindal, C., Mosquera, C., Holliday, E. G., & Biswas, T. (2017) · Cancer · doi:10.1002/cncr.30692 · Cited by 27
Wang, J., Hu, W., Wu, X., Wang, K., Yu, J., Luo, B., Luo, G., Wang, W., Wang, H., Li, J., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3428 · Cited by 22
DNA Topoisomerase III Alpha Regulates p53-Mediated Tumor Suppression
Hsieh, M., Fan, J.-R., Chang, H., Chen, H.-C., Shen, T., Teng, S., Yeh, Y.-H., & Li, T. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1997 · Cited by 14
Cited by
CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
Zhang, H., Deng, T., Liu, R., Ning, T., Yang, H., Liu, D., Zhang, Q., Lin, D., Ge, S., Bai, M., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01168-8 · Cited by 1,016
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Stromal cells in the tumor microenvironment: accomplices of tumor progression?
Zhao, Y., Shen, M., Wu, L., Yang, H., Yao, Y., Yang, Q., Du, J., Liu, L., Li, Y., & Bai, Y. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-06110-6 · Cited by 431
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Chen, S.-H., & Chang, J.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174136 · Cited by 428
Metadata
- Authors
- Zhai, J., Shen, J., Xie, G., Wu, J., He, M., Gao, L., Zhang, Y., Yao, X., & Shen, L.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 454
- Pages
- 37-43
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2938101988
- Cited by
- 272
- References
- 31
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.